CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Complement inhibitory stent coating reduces inflammation and neointima formation in New Zealand white rabbits
Authors
U Brehme
J Janzen
+3 more
G Tepe
J Trück
HP Wendel
Publication date
1 January 2008
Publisher
Abstract
Purpose: The purpose of this study was to investigate the role of inflammation during stent placement and the value of complement inhibition by stent coating with C1/C3 esterase inhibitor. Inflammation has been described as a major component of restenosis occurring after stent implantation. Methods: Animals were randomly assigned to one of 5 treatment groups and sacrificed after 4 days, and 6 weeks respectively. After 4 days uncoated bare metal control stents (C) (n=8) were compared with polyvinylpyrrolidone coated stents (P) (n=7), and after 6 weeks C stents (n=7) were compared with P stents (n=7) and P C1/C3 esterase inhibitor coated stents (PI) (n=7). AU morphometric measurements were performed on Elastica-van-Gieson stained segments, and the inflammation index (adapted from Kornowski et al.) was assessed using hematoxylin-eosin staining. Results: No acute or subacute thrombosis was observed. After 6 weeks neointima formation was 1.8±0.6 mm2 (bare stent) and 2.6±1.3 mm2 (P) in the control groups. In the treatment group (PI) neointima reduction was detectable (1.5±0.6 mm2). Inflammation was increased by P coating. In the PI stents the inflammation was significantly reduced compared to the P stents. Inflammation was noted 4 days after stent implantation with granulocytes whereas mononuclear infiltrates (lymphocytes, plasma cells) were predominant after 6 weeks. Conclusions: Inflammation is a key component of restenosis following stent administration. Inflammation can be reduced by C1/C3 esterase inhibitor coated stents. Because the hydrogel coating itself induced inflammation, this coating seems not to be the ideal for intravascular use. © Verlag PERFUSION GmbH
Similar works
Full text
Available Versions
Supporting member
Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:fc83be54...
Last time updated on 30/09/2015
ORA - Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:fc83be54...
Last time updated on 13/04/2022
Oxford University Research Archive (ORA)
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 18/04/2020